Greenwich LifeSciences, Inc. SEC filings GLSI
Greenwich LifeSciences, Inc. has 279 filings in SEC EDGAR's recent list, going back to Jan 27, 2020. Its latest annual report, Form ARS, was filed on Oct 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Dec 18, 2025 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Shareholder vote results
|
Dec 18, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Auditor change
|
Jul 24, 2025 | Jul 19, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Dec 19, 2024 | Dec 19, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 17, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Auditor change
|
Feb 20, 2024 | Feb 14, 2024 |
| 8-K |
Current report
Other events
|
Feb 14, 2024 | Feb 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Dec 15, 2023 | Dec 15, 2023 |
| 8-K |
Current report
Other events
|
Apr 13, 2023 | Apr 13, 2023 |
| 8-K |
Current report
Other events
|
Mar 13, 2023 | Mar 13, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Dec 9, 2022 | Dec 9, 2022 |
| 8-K |
Current report
Material agreement
|
Jul 12, 2022 | Jul 12, 2022 |
| 8-K |
Current report
Other events
|
Jul 12, 2022 | Jul 12, 2022 |
| 8-K |
Current report
Other events
|
Jul 11, 2022 | Jul 11, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Dec 15, 2021 | Dec 15, 2021 |
| 8-K |
Current report
Other events
|
Dec 13, 2021 | Dec 9, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 10, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Other events
|
Jun 10, 2021 | Jun 8, 2021 |
| 8-K |
Current report
Other events
|
Jun 9, 2021 | Jun 7, 2021 |
| 8-K |
Current report
Other events
|
Apr 20, 2021 | Apr 19, 2021 |
| 8-K |
Current report
Other events
|
Apr 15, 2021 | Apr 14, 2021 |
| 8-K |
Current report
Other events
|
Apr 13, 2021 | Apr 9, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 22, 2020 | Dec 17, 2020 |
| 8-K |
Current report
Other events
|
Dec 15, 2020 | Dec 15, 2020 |
| 8-K |
Current report
Other events
|
Dec 14, 2020 | Dec 11, 2020 |
| 8-K |
Current report
Other events
|
Dec 10, 2020 | Dec 9, 2020 |
| 8-K |
Current report
Other events
|
Nov 24, 2020 | Nov 23, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 19, 2020 | Nov 18, 2020 |
| 8-K |
Current report
Other events
|
Nov 13, 2020 | Nov 12, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 9, 2020 | Oct 6, 2020 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Other events
|
Oct 1, 2020 | Sep 29, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 28, 2020 | Sep 24, 2020 |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GLSI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Stafford, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1799788
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.